Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022
Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…Impact of SARS-CoV-2 vaccine in Parkinson’s disease
Objective: To evaluate the impact of SARS-CoV-2 vaccine on motor and non-motor symptoms in Mexican people with Parkinson's disease (PwP). Background: Nowadays, as a consequence…The impact of COVID-19 on Parkinson’s disease: a case-controlled registry and questionnaire study
Objective: The purpose of the study was to explore how having suffered through COVID-19 affects motor, nonmotor and general health aspects of Parkinson’s disease, and…Impact of Nonmotor Symptoms on The Quality of Life of Parkinson’s Disease Patients
Objective: This study examined the effect of nonmotor symptoms on the quality of life (QoL) of Parkinson's disease (PD) patients. Background: Parkinson's disease has a…Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results
Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform
Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…Data-driven prediction of fatigue in Parkinson’s disease patients
Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease
Objective: Objective: To develop and validate the Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD), a self-report scale designed to assess presence and severity of Gastrointestinal…Safinamide Improves Pain in Parkinson´s Disease. Results from the SAFINONMOTOR Study.
Objective: Our aim was to analyze the effectiveness of safinamide on pain in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…Obstructive sleep apnea and other vascular risk factors’ impact on Non-motor Symptoms in Parkinson’s Disease
Objective: To investigate the relationship between vascular comorbidity and non-motor symptoms in Parkinson’s Disease (PD) patients. Background: Previous studies suggested a significant association between the…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 51
- Next Page »